Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Rosen

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Transplantation|March 15, 2008
A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-upGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplantation|January 27, 2004
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 yearGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplantation|March 19, 2008
Campath-1H induction therapy in African American and Hispanic first renal transplant recipients: 3-year actuarial follow-upGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Clinical Transplantation|July 6, 2004
Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantationGaetano Ciancio, George W Burke, Adela Mattiazzi, et al.
Transplantation|July 16, 2008
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-upGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplantation|September 28, 2002
Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipientsGaetano Ciancio, George W Burke, Rolando Garcia-Morales, et al.
Human Immunology|February 16, 2010
Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assaysJames M Mathew, Gaetano Ciancio, George W Burke, et al.
Transplantation|August 19, 2004
The use of Campath-1H as induction therapy in renal transplantation: preliminary resultsGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplantation|August 27, 2005
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoringGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplantation|June 26, 2007
FoxP3 mRNA transcripts and regulatory cells in renal transplant recipients 10 years after donor marrow infusionRobert E Cirocco, Manuel R Carreño, James M Mathew, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Transplantation|March 15, 2008
A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-upGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplantation|January 27, 2004
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 yearGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplantation|March 19, 2008
Campath-1H induction therapy in African American and Hispanic first renal transplant recipients: 3-year actuarial follow-upGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Clinical Transplantation|July 6, 2004
Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantationGaetano Ciancio, George W Burke, Adela Mattiazzi, et al.
Transplantation|July 16, 2008
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-upGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplantation|September 28, 2002
Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipientsGaetano Ciancio, George W Burke, Rolando Garcia-Morales, et al.
Human Immunology|February 16, 2010
Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assaysJames M Mathew, Gaetano Ciancio, George W Burke, et al.
Transplantation|August 19, 2004
The use of Campath-1H as induction therapy in renal transplantation: preliminary resultsGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplantation|August 27, 2005
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoringGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Transplantation|June 26, 2007
FoxP3 mRNA transcripts and regulatory cells in renal transplant recipients 10 years after donor marrow infusionRobert E Cirocco, Manuel R Carreño, James M Mathew, et al.
Pageof 2